…
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and joint ventures. It provides its services under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Extendicare Inc operates and manages long-term care homes, retirement residences and home health services across Canada. An aging population, growing demand for community-based care and potential increases in public funding are long-term growth drivers, and investors may find the company attractive for its government-linked revenue mix and diversified care portfolio that could support stable cash flows.
Key risks include reliance on provincial funding and regulation, staffing shortages and wage pressure, capital-intensive asset needs and potential quality-of-care liabilities; investors should monitor occupancy and funding reforms.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 130.10M | 99.86M | 44.80M | -4.50M | 16.04M |
| Net income | 96.66M | 75.21M | 33.98M | -4.51M | 9.01M |
| Selling general administrative | 1357.88M | 1199.50M | 55.84M | 1164.12M | 1140.20M |
| Selling and marketing expenses | - | - | 1032.78M | - | - |
| Gross profit | 199.59M | 168.00M | 167.62M | 1221.58M | 1216.76M |
| Reconciled depreciation | 36.94M | 33.34M | 32.23M | 32.12M | 38.57M |
| Ebit | 138.37M | 121.94M | 66.41M | 20.99M | 56.62M |
| Ebitda | 175.61M | 155.27M | 98.63M | 53.11M | 95.19M |
| Depreciation and amortization | 37.25M | 33.34M | 32.23M | 32.12M | 38.57M |
| Operating income | 138.37M | 111.21M | 62.96M | 20.99M | 56.62M |
| Other operating expenses | 1522.04M | 1354.99M | 1242.37M | 1196.91M | 1162.01M |
| Interest expense | 19.23M | 21.10M | 21.60M | 20.61M | 27.20M |
| Tax provision | 33.45M | 24.65M | 10.82M | 0.01M | 7.03M |
| Interest income | 5.73M | 13.11M | 6.19M | 15.52M | 23.74M |
| Net interest income | -13.80M | -15.73M | -15.49M | -15.28M | -25.03M |
| Extraordinary items | - | - | 0.00M | 74.06M | 2.49M |
| Income tax expense | 33.45M | 24.65M | 10.82M | 0.01M | 7.03M |
| Total revenue | 1660.41M | 1466.20M | 1304.96M | 1221.58M | 1216.76M |
| Total operating expenses | 61.22M | 56.94M | 55.84M | 1196.91M | 1162.01M |
| Cost of revenue | 1460.82M | 1298.21M | 1137.34M | 1113.05M | 1070.41M |
| Total other income expense net | -8.26M | -11.35M | -18.16M | -25.48M | -40.58M |
| Discontinued operations | - | - | - | 74.06M | 2.49M |
| Net income from continuing ops | 96.66M | 75.21M | 33.98M | -4.51M | 9.01M |
| Net income applicable to common shares | - | 75.21M | 33.98M | 69.55M | 11.50M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1066.52M | 719.79M | 672.73M | 781.58M | 900.32M |
| Intangible assets | 103.07M | 75.06M | 78.46M | 51.21M | 46.63M |
| Other current assets | 17.58M | 28.82M | 20.20M | 23.98M | 26.47M |
| Total liab | 693.14M | 595.44M | 584.81M | 680.88M | 798.40M |
| Total stockholder equity | 373.37M | 124.35M | 87.92M | 100.70M | 101.92M |
| Other current liab | 11.59M | - | 3.25M | 5.61M | 15.34M |
| Common stock | 662.85M | - | 467.35M | 475.42M | 500.88M |
| Capital stock | 662.85M | 469.33M | 467.35M | 475.42M | 500.88M |
| Retained earnings | -299.68M | -352.55M | -393.47M | -384.62M | -402.45M |
| Other liab | - | - | - | 41.16M | 52.48M |
| Good will | 92.23M | 45.85M | 45.85M | 45.85M | 45.85M |
| Other assets | - | - | 0.00M | 37.76M | 47.32M |
| Cash | 349.18M | 121.85M | 75.91M | 167.28M | 104.63M |
| Cash and equivalents | - | - | - | 167.28M | 104.63M |
| Total current liabilities | 330.18M | 292.88M | 226.39M | 274.99M | 281.91M |
| Net debt | -6.25M | 170.64M | 258.60M | 216.69M | 432.22M |
| Short term debt | 19.85M | - | 19.88M | 19.24M | 73.58M |
| Short long term debt | 19.85M | 31.09M | 19.88M | 19.24M | 73.58M |
| Short long term debt total | 342.93M | - | 334.52M | 383.97M | 536.85M |
| Other stockholder equity | 16.29M | - | 13.09M | 17.70M | 15.27M |
| Property plant equipment | - | - | - | 388.72M | 535.60M |
| Total current assets | 451.93M | 243.70M | 187.14M | 258.04M | 224.92M |
| Long term investments | 24.47M | 24.75M | 24.53M | - | - |
| Net tangible assets | - | - | - | 3.64M | 9.44M |
| Net receivables | 85.17M | 88.74M | 91.03M | 64.07M | 83.54M |
| Long term debt | 310.36M | 261.39M | 314.64M | 364.74M | 463.27M |
| Inventory | - | - | - | 2.70M | 10.29M |
| Accounts payable | 298.74M | 241.50M | 203.26M | 250.14M | 192.99M |
| Accumulated other comprehensive income | -6.09M | - | 0.96M | -7.80M | -11.77M |
| Non currrent assets other | 33.45M | 29.43M | 34.98M | 30.47M | 32.89M |
| Non current assets total | 614.58M | 476.09M | 485.59M | 523.54M | 675.40M |
| Long term debt total | - | - | - | 364.74M | 463.27M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -9.11M | -84.45M | 155.64M | -63.73M |
| Change to liabilities | - | - | - | 48.62M | 15.45M |
| Total cashflows from investing activities | -119.02M | -9.11M | -84.45M | 155.64M | -63.73M |
| Net borrowings | 33.41M | -44.53M | 18.67M | -114.23M | -29.98M |
| Total cash from financing activities | 180.43M | -87.87M | -30.93M | -191.86M | -74.84M |
| Change to operating activities | - | - | - | 1.40M | 11.95M |
| Net income | 96.66M | 75.21M | 33.98M | 69.55M | 11.50M |
| Change in cash | 226.62M | 46.66M | -92.10M | 62.65M | -75.33M |
| Begin period cash flow | 122.56M | 75.18M | 167.28M | 104.63M | 179.96M |
| End period cash flow | 349.18M | 121.85M | 75.18M | 167.28M | 104.63M |
| Total cash from operating activities | 165.21M | 143.64M | 23.28M | 98.71M | 63.42M |
| Issuance of capital stock | 191.52M | - | - | - | - |
| Depreciation | 37.25M | 33.34M | 32.59M | 32.12M | 38.57M |
| Other cashflows from investing activities | 1.63M | 3.37M | 44.96M | 257.27M | 5.79M |
| Dividends paid | 41.70M | -40.02M | -40.43M | 42.55M | 42.99M |
| Change to account receivables | 18.56M | -3.58M | -29.20M | 4.04M | -13.77M |
| Sale purchase of stock | - | 0.00M | -11.06M | -35.02M | - |
| Other cashflows from financing activities | - | -3.31M | 1.89M | 1.31M | 0.48M |
| Change to netincome | - | - | - | -57.02M | -0.28M |
| Capital expenditures | 101.81M | 41.95M | 129.41M | 101.63M | 69.52M |
| Change in working capital | 57.02M | 22.85M | -41.20M | 54.06M | 13.63M |
| Stock based compensation | 0.70M | 1.89M | 4.20M | 2.64M | 3.57M |
| Other non cash items | -17.85M | -13.51M | -10.31M | -59.62M | -10.46M |
| Free cash flow | 63.40M | 101.69M | -106.13M | -2.92M | -6.10M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| EXE Extendicare Inc |
-0.33 1.19% |
27.48 | 25.21 | 23.92 | 1.59 | 7.26 | 1.62 | 14.43 |
| SIA Sienna Senior Living Inc |
0.02 0.10% |
20.43 | 45.94 | 38.17 | 2.23 | 3.17 | 3.57 | 21.90 |
| WELL WELL Health Technologies Corp |
-0.04 0.96% |
4.14 | - | 13.87 | 0.80 | 1.23 | 1.09 | 9.83 |
| DR Medical Facilities Corporation |
0.10 0.63% |
15.20 | 15.57 | 12.94 | 1.18 | 2.87 | 0.92 | 3.64 |
| AIDX HealWELL AI Inc. |
-0.01 1.54% |
0.64 | - | - | 2.81 | 2.35 | 3.46 | -4.93 |
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and joint ventures. It provides its services under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
| Name | Title | Year Born |
|---|---|---|
| Dr. Michael R. Guerriere M.D., MBA | CEO, Pres & Director | 1964 |
| Mr. David E. Bacon | Sr. VP & CFO | NA |
| Mr. John Toffoletto | Sr. VP, Chief Legal Officer & Corp. Sec. | NA |
| Ms. Leslie Sarauer | Sr. VP & Chief HR Officer | 1962 |
| Mr. Ali Mohammad Mir | VP, ParaMed Operations | NA |
| Mr. Steve Paraskevopoulos | Sr. VP of ParaMed & CTO | NA |
| Ms. Jillian E. Fountain | VP of Investor Relations | NA |
| Ms. Lisa Pearson | VP of Public Affairs | NA |
| Ms. Elaine E. Everson | VP of Corp. Devel. | NA |
| Dr. Matthew Morgan | Chief Medical Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.